The use of remdesivir outside of clinical trials during the COVID-19 pandemic

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 26 Sep 2020]

 

The use of remdesivir outside of clinical trials during the COVID-19 pandemic
With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antivira…
Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski and Aleksandra Grozdanova
Citation: Journal of Pharmaceutical Policy and Practice 2020 13:61
Content type: Commentary
Published on: 21 September 2020